JP Stock MarketDetailed Quotes

2929 Pharma Foods International

Watchlist
  • 942
  • -13-1.36%
20min DelayMarket Closed Aug 30 15:00 JST
27.39BMarket Cap8.83P/E (Static)

Pharma Foods International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Apr 30, 2024
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
Total revenue
-10.76%15.52B
-14.37%15.51B
-5.21%16.14B
13.94%68.57B
-0.59%16.04B
14.19%17.39B
11.71%18.11B
35.09%17.03B
28.73%60.19B
24.08%16.14B
Cost of revenue
-4.41%3.32B
-11.97%3.13B
6.87%3.42B
10.07%13.29B
-5.63%3.07B
14.10%3.47B
-8.17%3.55B
67.05%3.2B
71.87%12.08B
65.34%3.25B
Gross profit
-12.36%12.2B
-14.95%12.38B
-8.01%12.72B
14.91%55.28B
0.68%12.97B
14.22%13.92B
17.92%14.56B
29.36%13.83B
21.11%48.11B
16.73%12.89B
Operating expense
-8.17%10.47B
-13.59%11.45B
-24.37%12.11B
9.87%51.67B
-13.66%11B
-14.21%11.4B
11.45%13.25B
75.83%16.02B
38.11%47.03B
59.26%12.74B
Selling and administrative expenses
-9.85%8.42B
-16.46%9.21B
-28.11%9.94B
9.71%42.96B
-16.73%8.77B
-18.03%9.34B
13.13%11.03B
84.75%13.82B
41.81%39.16B
67.89%10.54B
-Selling and marketing expense
-10.86%7.41B
-18.52%8.18B
-31.15%8.81B
8.72%38.87B
-19.49%7.72B
-21.20%8.31B
12.96%10.04B
90.19%12.8B
43.80%35.75B
74.52%9.59B
-General and administrative expense
-1.74%1.01B
4.33%1.04B
10.11%1.12B
20.05%4.1B
11.19%1.05B
21.13%1.03B
14.95%992M
35.87%1.02B
23.89%3.41B
21.25%947M
Research and development costs
19.89%223M
-0.97%205M
34.47%277M
9.66%840M
-17.18%241M
12.73%186M
25.45%207M
42.07%206M
46.74%766M
73.21%291M
Depreciation and amortization
0.00%18M
110.53%40M
35.29%23M
41.18%72M
5.88%18M
38.46%18M
72.73%19M
70.00%17M
18.60%51M
54.55%17M
-Depreciation
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Amortization
0.00%18M
110.53%40M
35.29%23M
41.18%72M
5.88%18M
38.46%18M
72.73%19M
70.00%17M
18.60%51M
54.55%17M
Other operating expenses
-2.59%1.81B
-0.25%1.99B
-4.91%1.88B
10.57%7.79B
3.80%1.97B
8.23%1.86B
1.58%2B
33.97%1.98B
20.09%7.05B
22.68%1.89B
Operating profit
-31.31%1.73B
-28.70%934M
127.50%603M
233.83%3.61B
1,234.46%1.98B
328.88%2.52B
186.03%1.31B
-239.06%-2.19B
-80.93%1.08B
-95.13%148M
Net non-operating interest income (expenses)
-23.08%-16M
-18.18%-13M
-16.67%-14M
-95.83%-47M
-57.14%-11M
-160.00%-13M
-10.00%-11M
-500.00%-12M
-166.67%-24M
-250.00%-7M
Non-operating interest income
0.00%1M
--0
--0
-50.00%1M
--0
--1M
-700.00%-6M
--6M
-33.33%2M
0.00%1M
Non-operating interest expense
21.43%17M
160.00%13M
-22.22%14M
84.62%48M
37.50%11M
180.00%14M
-54.55%5M
800.00%18M
116.67%26M
166.67%8M
Net investment income
266.67%5M
1,000.00%11M
-50.00%6M
-53.42%34M
20.00%24M
-110.00%-3M
-93.75%1M
71.43%12M
284.21%73M
766.67%20M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
10M
0
-2M
-6,300.00%-64M
-5,300.00%-54M
0
-10M
0
-1M
-1M
Income from associates and other participating interests
-21.74%-28M
103.85%1M
91.67%-1M
-1,740.00%-82M
-200.00%-21M
-483.33%-23M
-620.00%-26M
-1,300.00%-12M
-68.75%5M
-200.00%-7M
Special income (charges)
-98.74%2M
0
16,000.00%159M
7,800.00%77M
Less:Restructuring and mergern&acquisition
----
----
----
--0
----
----
----
----
---82M
--0
Less:Other special charges
----
----
----
97.40%-2M
--0
----
----
----
-7,800.00%-77M
----
Other non-operating income (expenses)
-157.89%-11M
100.00%6M
-50.00%13M
-31.01%89M
20.59%41M
-53.66%19M
-85.00%3M
-23.53%26M
92.54%129M
209.09%34M
Income before tax
-32.21%1.69B
-26.10%937M
127.75%605M
148.91%3.54B
638.87%1.96B
342.80%2.5B
160.37%1.27B
-228.31%-2.18B
-75.32%1.42B
-91.31%265M
Income tax
17.54%603M
25.97%456M
188.58%318M
-74.29%462M
-115.21%-54M
-37.21%513M
129.11%362M
-176.87%-359M
-6.60%1.8B
-53.47%355M
Net income
-45.11%1.09B
-46.74%482M
115.71%286M
923.53%3.08B
2,336.67%2.01B
207.43%1.98B
174.24%905M
-247.85%-1.82B
-109.74%-374M
-103.93%-90M
Net income continuous operations
-45.08%1.09B
-46.91%481M
115.76%287M
923.53%3.08B
2,335.56%2.01B
207.48%1.98B
175.38%906M
-247.81%-1.82B
-109.74%-374M
-103.94%-90M
Noncontrolling interests
0
0
0
0
0
1M
-1M
0
0
0
Net income attributable to the company
-45.11%1.09B
-46.80%482M
115.71%286M
923.80%3.08B
2,336.67%2.01B
207.43%1.98B
174.55%906M
-247.85%-1.82B
-109.74%-374M
-103.93%-90M
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
-45.11%1.09B
-46.80%482M
115.71%286M
923.80%3.08B
2,336.67%2.01B
207.43%1.98B
174.55%906M
-247.85%-1.82B
-109.74%-374M
-103.93%-90M
Gross dividend payment
Basic earnings per share
-44.16%38.32
-46.28%16.74
115.83%9.94
927.77%106.7
2,348.39%69.7
207.81%68.62
173.09%31.16
-247.89%-62.78
-109.75%-12.89
-103.94%-3.1
Diluted earnings per share
-44.16%38.32
-46.28%16.74
115.83%9.94
927.77%106.7
2,347.54%69.7
207.73%68.62
173.09%31.16
-247.96%-62.78
-109.75%-12.89
-103.94%-3.1012
Dividend per share
0
0.00%10
0
10.00%22
20.00%12
0
0.00%10
0
100.00%20
100.00%10
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Apr 30, 2024(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022
Total revenue -10.76%15.52B-14.37%15.51B-5.21%16.14B13.94%68.57B-0.59%16.04B14.19%17.39B11.71%18.11B35.09%17.03B28.73%60.19B24.08%16.14B
Cost of revenue -4.41%3.32B-11.97%3.13B6.87%3.42B10.07%13.29B-5.63%3.07B14.10%3.47B-8.17%3.55B67.05%3.2B71.87%12.08B65.34%3.25B
Gross profit -12.36%12.2B-14.95%12.38B-8.01%12.72B14.91%55.28B0.68%12.97B14.22%13.92B17.92%14.56B29.36%13.83B21.11%48.11B16.73%12.89B
Operating expense -8.17%10.47B-13.59%11.45B-24.37%12.11B9.87%51.67B-13.66%11B-14.21%11.4B11.45%13.25B75.83%16.02B38.11%47.03B59.26%12.74B
Selling and administrative expenses -9.85%8.42B-16.46%9.21B-28.11%9.94B9.71%42.96B-16.73%8.77B-18.03%9.34B13.13%11.03B84.75%13.82B41.81%39.16B67.89%10.54B
-Selling and marketing expense -10.86%7.41B-18.52%8.18B-31.15%8.81B8.72%38.87B-19.49%7.72B-21.20%8.31B12.96%10.04B90.19%12.8B43.80%35.75B74.52%9.59B
-General and administrative expense -1.74%1.01B4.33%1.04B10.11%1.12B20.05%4.1B11.19%1.05B21.13%1.03B14.95%992M35.87%1.02B23.89%3.41B21.25%947M
Research and development costs 19.89%223M-0.97%205M34.47%277M9.66%840M-17.18%241M12.73%186M25.45%207M42.07%206M46.74%766M73.21%291M
Depreciation and amortization 0.00%18M110.53%40M35.29%23M41.18%72M5.88%18M38.46%18M72.73%19M70.00%17M18.60%51M54.55%17M
-Depreciation --0--0--0--0--0--0--0--0--0--0
-Amortization 0.00%18M110.53%40M35.29%23M41.18%72M5.88%18M38.46%18M72.73%19M70.00%17M18.60%51M54.55%17M
Other operating expenses -2.59%1.81B-0.25%1.99B-4.91%1.88B10.57%7.79B3.80%1.97B8.23%1.86B1.58%2B33.97%1.98B20.09%7.05B22.68%1.89B
Operating profit -31.31%1.73B-28.70%934M127.50%603M233.83%3.61B1,234.46%1.98B328.88%2.52B186.03%1.31B-239.06%-2.19B-80.93%1.08B-95.13%148M
Net non-operating interest income (expenses) -23.08%-16M-18.18%-13M-16.67%-14M-95.83%-47M-57.14%-11M-160.00%-13M-10.00%-11M-500.00%-12M-166.67%-24M-250.00%-7M
Non-operating interest income 0.00%1M--0--0-50.00%1M--0--1M-700.00%-6M--6M-33.33%2M0.00%1M
Non-operating interest expense 21.43%17M160.00%13M-22.22%14M84.62%48M37.50%11M180.00%14M-54.55%5M800.00%18M116.67%26M166.67%8M
Net investment income 266.67%5M1,000.00%11M-50.00%6M-53.42%34M20.00%24M-110.00%-3M-93.75%1M71.43%12M284.21%73M766.67%20M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 10M0-2M-6,300.00%-64M-5,300.00%-54M0-10M0-1M-1M
Income from associates and other participating interests -21.74%-28M103.85%1M91.67%-1M-1,740.00%-82M-200.00%-21M-483.33%-23M-620.00%-26M-1,300.00%-12M-68.75%5M-200.00%-7M
Special income (charges) -98.74%2M016,000.00%159M7,800.00%77M
Less:Restructuring and mergern&acquisition --------------0-------------------82M--0
Less:Other special charges ------------97.40%-2M--0-------------7,800.00%-77M----
Other non-operating income (expenses) -157.89%-11M100.00%6M-50.00%13M-31.01%89M20.59%41M-53.66%19M-85.00%3M-23.53%26M92.54%129M209.09%34M
Income before tax -32.21%1.69B-26.10%937M127.75%605M148.91%3.54B638.87%1.96B342.80%2.5B160.37%1.27B-228.31%-2.18B-75.32%1.42B-91.31%265M
Income tax 17.54%603M25.97%456M188.58%318M-74.29%462M-115.21%-54M-37.21%513M129.11%362M-176.87%-359M-6.60%1.8B-53.47%355M
Net income -45.11%1.09B-46.74%482M115.71%286M923.53%3.08B2,336.67%2.01B207.43%1.98B174.24%905M-247.85%-1.82B-109.74%-374M-103.93%-90M
Net income continuous operations -45.08%1.09B-46.91%481M115.76%287M923.53%3.08B2,335.56%2.01B207.48%1.98B175.38%906M-247.81%-1.82B-109.74%-374M-103.94%-90M
Noncontrolling interests 000001M-1M000
Net income attributable to the company -45.11%1.09B-46.80%482M115.71%286M923.80%3.08B2,336.67%2.01B207.43%1.98B174.55%906M-247.85%-1.82B-109.74%-374M-103.93%-90M
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders -45.11%1.09B-46.80%482M115.71%286M923.80%3.08B2,336.67%2.01B207.43%1.98B174.55%906M-247.85%-1.82B-109.74%-374M-103.93%-90M
Gross dividend payment
Basic earnings per share -44.16%38.32-46.28%16.74115.83%9.94927.77%106.72,348.39%69.7207.81%68.62173.09%31.16-247.89%-62.78-109.75%-12.89-103.94%-3.1
Diluted earnings per share -44.16%38.32-46.28%16.74115.83%9.94927.77%106.72,347.54%69.7207.73%68.62173.09%31.16-247.96%-62.78-109.75%-12.89-103.94%-3.1012
Dividend per share 00.00%10010.00%2220.00%1200.00%100100.00%20100.00%10
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg